Singapore total exports up 12% in November

Yet it is a slow growth compared to October's 20% y-o-y growth.

HSBC said that non-oil domestic exports (NODX), a better gauge of value-added, also saw slower growth (10% vs. 35% y-o-y in October). This was well-below our forecast (23.4% y-o-y) and that of consensus (21.5% y-o-y). Moreover, NODX sequential growth turned negative (-13% m-o-m sa vs. 5.8% the month before).

By products, NODX saw slower growth for both electronics exports (11% y-o-y vs. 34% in October) and non-electronics exports (9.5% y-o-y vs. 35% in September). Electronics exports growth slowed for all the top 5 categories, in some cases (parts of ICs) partly reflecting a base effect. For non-electronics, the big drag was our old volatile friend pharmaceuticals, plummeting 34% y-o-y (vs. 26.2% in October).

By markets, NODX growth for the EU slowed markedly (20% y-o-y) following the dizzying 70% y-o-y jump in October. The growth slowdown for the US was of a similar magnitude (13% y-o-y vs. 72.2% the previous month). NODX destined for China also grew at a slower pace, although the slowdown was not as drastic (37% vs. 43% in October). All three markets saw slower growth for both electronics and non-electronics.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.